My Testosterone problem

vic

Member
I have a problem taking testosterone now. I am 70 years old. The standard testosterone level is 380 to 400 ng/dL. Mine is 90. PSA is normal. What should I do?

Background: I was diagnosed with HIV in 1986. In 2001 I had non-Hodgkins lymphoma, with six months of chemotherapy. After that my T-cells were ~20. I was diagnosed with hypogonadism and had adrenal insufficiency. Since then I have been taking testosterone supplements. In 2006 I received a new combination therapy and my viral load became undetectable and T-cell began to rise. In 2024 I was on 50 mg (0.5 mL) per week of subcutaneous testosterone. When I developed severe urinary flow problems, I had a Aquablation procedure for BPH, and since then I am not able to take testosterone. I tried with a low level gel but as soon as I take it I develop urinary retention. So I have stopped all testosterone. My level of testosterone now is 90.
 
I have a problem taking testosterone now. I am 70 years old. The standard testosterone level is 380 to 400 ng/dL. Mine is 90. PSA is normal. What should I do?

Background: I was diagnosed with HIV in 1986. In 2001 I had non-Hodgkins lymphoma, with six months of chemotherapy. After that my T-cells were ~20. I was diagnosed with hypogonadism and had adrenal insufficiency. Since then I have been taking testosterone supplements. In 2006 I received a new combination therapy and my viral load became undetectable and T-cell began to rise. In 2024 I was on 50 mg (0.5 mL) per week of subcutaneous testosterone. When I developed severe urinary flow problems, I had a Aquablation procedure for BPH, and since then I am not able to take testosterone. I tried with a low level gel but as soon as I take it I develop urinary retention. So I have stopped all testosterone. My level of testosterone now is 90.

True vet here as you have been a member of the forum from the start!

Blessed that you found one of the few forums that changed the game as we run in a different lane over here.

No mumbo jumbo or fluff here we keep it real!

You definitely need to address this as your TT 90 ng/dL is horribly low which means the most critical fraction FT would be absurdly low and you are at a huge disadvantage here when it comes to your overall health (mental/physical) especially cardiovascular and bone health.

More importantly, its metabolites estradiol and DHT are needed in healthy amounts to experience the full spectrum of testosterone-beneficial effects on (cardiovascular health, brain health, libido, erectile function, bone health, tendon health, immune system, lipids, and body composition).


*Natural testosterone is viewed as the best androgen for substitution in hypogonadal men. The reason behind the selection is that testosterone can be converted to DHT and E2, thus developing the full spectrum of testosterone activities in long-term substitution

*Preparations of native testosterone or its esters (aromatizable T) should be used for TTh


You need to seek out a urologist who also specializes in testosterone therapy and can address your situation.

50 mg T is a low weekly dose and chances are your FT especially trough may have been too low.

Standard starting dose across the board by those in the know is 100 mg T/week or 50 mg T injected twice-weekly.

Yes there are many ends and some uros who will start older men on 60-80 mg T/week.

Rare any would go below 60 mg T/week.

Blood work should have been done at the true trough (lowest point) before your next injection so you can make sure you are still hitting a healthy FT level otherwise you can experiences symptoms of low-T towards the end of the week.

Although blood levels will be more stable throughout the week when injecting strictly sub-q there is still going to be a difference between the peak--->trough when injecting once weekly.

Do you have any of your previous. labs to post (TT, FT, estradiol and SHBG) and if so how many days post-injection were they done?

The standard starting dose for Xyosted is 75 mg T/week.

Have you had. any follow-up testing since the mist (aquablation) procedure?

What were your symptoms before the procedure and what improvements did you notice after?

Being in a hypogonadal state would be worse in the long-run for LUTS/BPH let alone your overall health.

In cases of men with severe LUTS use of testosterone needs to be approached cautiously and the condition needs to be addressed/treated.


* Meta-analyses have not found significant changes in LUTS between patients treated with testosterone or placebo [143-149]. According to the literature, there are no grounds to discourage testosterone therapy in hypogonadal patients with BPH/LUTS and there is evidence of limited benefit from androgen administration. The only concern is related to patients with severe LUTS (IPSS > 19), as they are usually excluded from RCTs; therefore, limiting the long-term safety data of testosterone therapy in this specific setting [68].





3.5.3 Lower urinary tract symptoms/benign prostatic hyperplasia

A trial of 60 patients undergoing testosterone therapy for six months showed no significant differences on post-void residual urine and prostate volume, while storage symptoms as measured by IPSS significantly improved, despite an increase in prostate-specific antigen (PSA) level [138]. A larger pre-treatment prostate volume was a predictive factor of improvement in LUTS. Similarly, a placebo controlled RCT including 120 men with hypogonadism (total testosterone < 12nmol/L) with MetS and listed for benign prostatic hyperplasia (BPH) surgery, showed that testosterone therapy did not result in a difference in LUTS severity compared to placebo. Conversely, an improvement in ultrasound (US) markers of inflammation in the expression of several pro-inflammatory genes was found in the treatment active arm [139]. A long-term study of 428 men undergoing testosterone therapy for eight years demonstrated significant improvements in IPSS, no changes in maximum flow rate (Qmax) and residual urine volume, but also a significant increase in prostate volume [140]. Similar data from the Registry of Hypogonadism in Men (RHYME), including 999 patients with a follow-up of three years, did not demonstrate any significant difference in PSA levels or total IPSS in men undergoing testosterone therapy, compared to untreated patients [141]. Similar results were reported in an Italian registry (SIAMO- NOI), collecting data from 432 men with hypogonadism from 15 centres [142]. Meta-analyses have not found significant changes in LUTS between patients treated with testosterone or placebo [143-149]. According to the literature, there are no grounds to discourage testosterone therapy in hypogonadal patients with BPH/LUTS and there is evidence of limited benefit from androgen administration. The only concern is related to patients with severe LUTS (IPSS > 19), as they are usually excluded from RCTs; therefore, limiting the long-term safety data of testosterone therapy in this specific setting [68].












 
Doubtful you were hitting a high enough FT injecting 50 mg TC or TE once weekly even when using a novel formulation such as Xyosted.



2.2 Starting Dose and Dose Adjustment

The starting dose of XYOSTED is 75 mg, administered subcutaneously in the abdominal region once a week.


Dose adjustment

Measure total testosterone trough concentrations (measured 7 days after the most recent dose) following 6 weeks of dosing, following 6 weeks after dose adjustment, and periodically while on treatment with XYOSTED. A trough concentration between 350 ng/dL and 650 ng/dL generally provides testosterone exposures in the normal range during the entire dosing interval. Decrease the dose by 25 mg if the total testosterone trough concentration (Ctrough) is ≥650 ng/dL. Increase the dose by 25 mg if the total testosterone Ctrough is <350 ng/dL. Maintain the same dose if the total testosterone Ctrough is ≥350 ng/dL and <650 ng/dL.




 
True vet here as you have been a member of the forum from the start!

Blessed that you found one of the few forums that changed the game as we run in a different lane over here.

No mumbo jumbo or fluff here we keep it real!

You definitely need to address this as your TT 90 ng/dL is horribly low which means the most critical fraction FT would be absurdly low and you are at a huge disadvantage here when it comes to your overall health (mental/physical) especially cardiovascular and bone health.

More importantly, its metabolites estradiol and DHT are needed in healthy amounts to experience the full spectrum of testosterone-beneficial effects on (cardiovascular health, brain health, libido, erectile function, bone health, tendon health, immune system, lipids, and body composition).


*Natural testosterone is viewed as the best androgen for substitution in hypogonadal men. The reason behind the selection is that testosterone can be converted to DHT and E2, thus developing the full spectrum of testosterone activities in long-term substitution

*Preparations of native testosterone or its esters (aromatizable T) should be used for TTh


You need to seek out a urologist who also specializes in testosterone therapy and can address your situation.

50 mg T is a low weekly dose and chances are your FT especially trough may have been too low.

Standard starting dose across the board by those in the know is 100 mg T/week or 50 mg T injected twice-weekly.

Yes there are many ends and some uros who will start older men on 60-80 mg T/week.

Rare any would go below 60 mg T/week.

Blood work should have been done at the true trough (lowest point) before your next injection so you can make sure you are still hitting a healthy FT level otherwise you can experiences symptoms of low-T towards the end of the week.

Although blood levels will be more stable throughout the week when injecting strictly sub-q there is still going to be a difference between the peak--->trough when injecting once weekly.

Do you have any of your previous. labs to post (TT, FT, estradiol and SHBG) and if so how many days post-injection were they done?

The standard starting dose for Xyosted is 75 mg T/week.

Have you had. any follow-up testing since the mist (aquablation) procedure?

What were your symptoms before the procedure and what improvements did you notice after?

Being in a hypogonadal state would be worse in the long-run for LUTS/BPH let alone your overall health.

In cases of men with severe LUTS use of testosterone needs to be approached cautiously and the condition needs to be addressed/treated.


* Meta-analyses have not found significant changes in LUTS between patients treated with testosterone or placebo [143-149]. According to the literature, there are no grounds to discourage testosterone therapy in hypogonadal patients with BPH/LUTS and there is evidence of limited benefit from androgen administration. The only concern is related to patients with severe LUTS (IPSS > 19), as they are usually excluded from RCTs; therefore, limiting the long-term safety data of testosterone therapy in this specific setting [68].





3.5.3 Lower urinary tract symptoms/benign prostatic hyperplasia

A trial of 60 patients undergoing testosterone therapy for six months showed no significant differences on post-void residual urine and prostate volume, while storage symptoms as measured by IPSS significantly improved, despite an increase in prostate-specific antigen (PSA) level [138]. A larger pre-treatment prostate volume was a predictive factor of improvement in LUTS. Similarly, a placebo controlled RCT including 120 men with hypogonadism (total testosterone < 12nmol/L) with MetS and listed for benign prostatic hyperplasia (BPH) surgery, showed that testosterone therapy did not result in a difference in LUTS severity compared to placebo. Conversely, an improvement in ultrasound (US) markers of inflammation in the expression of several pro-inflammatory genes was found in the treatment active arm [139]. A long-term study of 428 men undergoing testosterone therapy for eight years demonstrated significant improvements in IPSS, no changes in maximum flow rate (Qmax) and residual urine volume, but also a significant increase in prostate volume [140]. Similar data from the Registry of Hypogonadism in Men (RHYME), including 999 patients with a follow-up of three years, did not demonstrate any significant difference in PSA levels or total IPSS in men undergoing testosterone therapy, compared to untreated patients [141]. Similar results were reported in an Italian registry (SIAMO- NOI), collecting data from 432 men with hypogonadism from 15 centres [142]. Meta-analyses have not found significant changes in LUTS between patients treated with testosterone or placebo [143-149]. According to the literature, there are no grounds to discourage testosterone therapy in hypogonadal patients with BPH/LUTS and there is evidence of limited benefit from androgen administration. The only concern is related to patients with severe LUTS (IPSS > 19), as they are usually excluded from RCTs; therefore, limiting the long-term safety data of testosterone therapy in this specific setting [68].












>> Have you had. any follow-up testing since the mist (aquablation) procedure?

Yes, I had a cystoscopy done nine months later. It was normal. The urologist said that the problem is the Testosterone therapy and I should consult a endocrinologist. The endocrinologist lowered my Testosterone dose to a very minimum with gel. After trying the gel, my conclusion was even the small dose of Testosterone makes my urinary symptoms get worse.

>> What were your symptoms before the procedure and what improvements did you notice after?

Before the aquablation the BPH had gotten worse and I had to use a catheter for urination. After the aquablation for four months I had a normal urine flow. But then I started having BPH symptoms.
 
>> Have you had. any follow-up testing since the mist (aquablation) procedure?

Yes, I had a cystoscopy done nine months later. It was normal. The urologist said that the problem is the Testosterone therapy and I should consult a endocrinologist. The endocrinologist lowered my Testosterone dose to a very minimum with gel. After trying the gel, my conclusion was even the small dose of Testosterone makes my urinary symptoms get worse.

>> What were your symptoms before the procedure and what improvements did you notice after?

Before the aquablation the BPH had gotten worse and I had to use a catheter for urination. After the aquablation for four months I had a normal urine flow. But then I started having BPH symptoms.

I would still seek out a second opinion from another urologist who is more up to date and specializes in T-therapy.

Would need to look into more follow-up testing (LUTS/BPH) symptoms.

When was the last time you had IPSS testing. and what was the score?

Where do you live?
 
I would still seek out a second opinion from another urologist who is more up to date and specializes in T-therapy.

Would need to look into more follow-up testing (LUTS/BPH) symptoms.

When was the last time you had IPSS testing. and what was the score?

Where do you live?
>> When was the last time you had IPSS testing. and what was the score?

No IPSS test was done in my records

>> Where do you live?

I live in Washington, DC. Do you any recommendation for a urologist who also specialises in TRT?
 
>> When was the last time you had IPSS testing. and what was the score?

No IPSS test was done in my records

>> Where do you live?

I live in Washington, DC. Do you any recommendation for a urologist who also specialises in TRT?

1773444489489.webp





Dr. Kelly A. Chiles is a board-certified urologist practicing in Washington, DC.

She used to work at Weill Cornell Medical College in New York earlier in her career.

Chiles specializes in hypogonadism, erectile dysfunction, and men's sexual health.

She should be well versed with complex cases and there are other urologists from the same network such as Dr. Nathan Shaw that are well versed.

She co-authored this landmark paper with a few other heavyweights in the field Dr. Mulhall, Dr. Brannigan, Dr. Miner and Dr. Trost.


Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018)

John P. Mulhall, Landon W. Trost, Robert E. Brannigan, Emily G. Kurtz, J. Bruce Redmon, Kelly A. Chiles, Deborah J. Lightner, Martin M. Miner, M. Hassan Murad, Christian J. Nelson, Elizabeth A. Platz, Lakshmi V. Ramanathan and Ronald W. Lewis









 
Madman has given you great info.

Here’s the full combined reply:

Vic, your situation is genuinely complex and you deserve a thoughtful, nuanced answer — not a one-size-fits-all response.

Your history — HIV since 1986, non-Hodgkin’s lymphoma, chemotherapy-induced hypogonadism and adrenal insufficiency, decades of successful TRT, and now BPH with urinary retention triggered by testosterone — puts you in a category that most TRT discussions simply don’t address adequately.

Let’s work through this carefully.

Why is testosterone causing urinary retention after Aquablation?

This is the key question. Testosterone stimulates prostate tissue partly through its conversion to DHT (dihydrotestosterone), which can worsen lower urinary tract symptoms (LUTS). However, you had Aquablation specifically to resolve BPH obstruction — so immediate retention after low-dose gel suggests one or more of these possibilities:

∙ The prostate is still healing or inflamed post-procedure
∙ You may be a high DHT converter
∙ There could be a secondary issue worth investigating — urethral stricture or bladder dysfunction

Before giving up on testosterone entirely, there is a very reasonable next step.

Consider an Alpha-1 Blocker First

Rather than a 5-alpha reductase inhibitor (finasteride, dutasteride) — which I would not recommend given their well-documented risk of sexual side effects including erectile dysfunction, loss of libido, and in some men persistent post-finasteride syndrome — alpha-1 blockers are a far better fit for your situation.

Medications like tamsulosin (Flomax, 0.4mg) or silodosin (Rapaflo) work by relaxing smooth muscle in the prostate and bladder neck. Key advantages for you specifically:

∙ No hormonal interference — they don’t affect DHT or blunt testosterone’s benefits
∙ Fast acting — urinary symptom relief often within days, not months like 5-ARIs
∙ No sexual side effects — some men actually report improved sensation
∙ Well tolerated in older men and generally in HIV+ patients, though drug interactions with your antiretrovirals should be reviewed with your pharmacist or HIV specialist
∙ Tamsulosin is the most commonly used and best studied option

One important caution: Alpha blockers can cause orthostatic hypotension (dizziness when standing up), which is worth monitoring carefully at 70, particularly if you take any blood pressure medications.

A Practical Path Forward

Here is a reasonable stepwise approach to discuss with your doctors:
1. Start an alpha-1 blocker (tamsulosin 0.4mg is the typical first choice) and allow 2–4 weeks to assess urinary symptom relief
2. Allow adequate healing time post-Aquablation — prostate tissue can remain reactive for several months after the procedure
3. Cautiously reintroduce very low-dose testosterone — a small 25 mg subcutaneous injection 3 times per week may actually be easier to titrate than gel, and avoids the variable absorption that gel carries
4. Monitor closely — urinary flow rate, symptom scores, and testosterone levels together

Don’t overlook the bigger picture

At a testosterone level of 90 ng/dL, you are almost certainly experiencing real consequences — fatigue, muscle loss, cognitive changes, mood shifts, and accelerating bone density decline. These are not trivial at 70, and they are especially significant given your HIV history.

Long-term HIV and antiretroviral therapy are themselves independently associated with hypogonadism, metabolic dysfunction, and osteoporosis. Your HIV/infectious disease specialist should be part of this conversation alongside your urologist and endocrinologist. This is a case that calls for a team approach.
Your adrenal insufficiency history also matters here — low testosterone in that context is not just a quality-of-life issue. It has real physiological implications.

You have been navigating extraordinarily complex medical terrain for nearly 40 years. You deserve better than simply being told to stop testosterone and live with it. Push for a joint consultation between your urologist and endocrinologist, specifically asking about:

∙ Alpha-1 blocker therapy as a bridge and ongoing support for urinary function
∙ Low-dose testosterone reintroduction once urinary symptoms are controlled
∙ Bone density assessment (DEXA scan) given your cumulative risk factors
∙ Review of drug interactions between any new medications and your HIV regimen
You have options. Don’t give up on this yet.
— Nelson

PS: also poz here since 1986 and had lymphoma.
 

ExcelMale Newsletter Signup

Online statistics

Members online
2
Guests online
519
Total visitors
521

Latest posts

Beyond Testosterone Podcast

Back
Top